Company Liquidation PRIVATE-LIMITED-GUARANT-NSC

Company profile

Roslin Cells Limited

RoslinCells.com

Former domain of the website of a leading UK Cell Therapy Contract Development and Manufacturing Organisation.

CRN
SC290425
Founded
2005
Age
18

Overview

Legal name
ROSLIN CELLS LIMITED
Region
Scotland
Registered address
Unknown
Insolvency history
Yes

Company events

Reference milestones and recent Companies House filing stream events.

1 event
16 Sep
2005

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2010
Funded years
2010, 2012
Age at first award
4 years

Projects

2012 Feasibility Studies Lead participant

Improving the Clinical Utility of Umbilical Cord Blood Donations by Ex-Vivo Expansion Using Mesenchymal Stromal Cells

1 Nov 2012 to 31 Dec 2013

Awarded
£124,148
Total cost £165,530

This project will assess the feasibility of improving the clinical utility of umbilical cord blood (UCB) through ex vivo expansion mediated by co-culture with mesenchymal stromal cells (MSCs). We have patented technology for the production pluripotent stem cell derived MSCs, which means that we can supply these cells in almost limitless quantities. The ha...

2012 Collaborative R&D

Development of a GMP cryogenic cold chain for clinical delivery of regenerative medicine therapeutics

1 Apr 2012 to 30 Jun 2015

Awarded
£53,173
Total cost £88,621

Asymptote Ltd is proposing to develop the first GMP compliant cryogenic cold chain for the clinical delivery of regenerative medicine therapeutics. This project focuses on the key elements of the cold chain: controlled rate freezing of large volumes, short and long term frozen storage, and controlled thawing of large volumes. Cryopreservation of cells wit...

2010 Fast Track Lead participant

Clinical translation of endothelial cells derived from human embryonic stem cells

1 Aug 2010 to 31 Mar 2011

Awarded
£103,000
Total cost £171,600

Awaiting Public Summary

2010 Collaborative R&D

A Therapy Realization Pathway Tool (TRPT) applied to three representative regenerative medicine therapeutic products: REALISE

1 May 2010 to 30 Apr 2012

Awarded
£109,000
Total cost £178,300

This project,completed in April 2012 developed several tools for the regenerative medicine sector. Named the Realise project this innovative collaboration has provided a web-based toolkit to support the development of regenerative medicine therapies from early development through to spin out and full commercialisation. The Scottish Stem Cell Network has l...

Product types

Collaborative R&D Fast Track Feasibility Studies